a public good project by the
Synthesis
Company
of California

© 2026

Michelle Letarte | doi.page

0 works0 citations0 h-index

Michelle Letarte

Publications by Year

Research Areas

Monoclonal and Polyclonal Antibodies Research, Vascular Anomalies and Treatments, Glycosylation and Glycoproteins Research, Tracheal and airway disorders, TGF-β signaling in diseases

Most-Cited Works

→ Soluble endoglin contributes to the pathogenesis of preeclampsia(2006)1,832 cited
→ Endoglin, a TGF-β binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1(1994)1,489 cited
→ Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells.(1992)834 cited
→ Endoglin Is an Accessory Protein That Interacts with the Signaling Receptor Complex of Multiple Members of the Transforming Growth Factor-β Superfamily(1999)559 cited
→ A murine model of hereditary hemorrhagic telangiectasia(1999)471 cited
→ Primary structure of endoglin, an RGD-containing glycoprotein of human endothelial cells.(1990)453 cited
→

Rare diseases bullet 4: Hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations: issues in clinical management and review of pathogenic mechanisms

(1999)

358 cited

Up-regulation of endoglin on vascular endothelial cells in human solid tumors: implications for diagnosis and therapy.(1995)

→ Common acute lymphocytic leukemia antigen is identical to neutral endopeptidase.(1988)327 cited

→ Endoglin modulates cellular responses to TGF-beta 1.(1996)306 cited